{"id":7,"date":"2019-07-24T09:33:07","date_gmt":"2019-07-24T09:33:07","guid":{"rendered":"http:\/\/ecn2020.www.bioevents.net?page_id=7"},"modified":"2023-11-14T08:13:11","modified_gmt":"2023-11-14T08:13:11","slug":"med-cannabis","status":"publish","type":"page","link":"https:\/\/immuno-oncology2023.com\/","title":{"rendered":"home"},"content":{"rendered":"\t\t
4th Immuno-Oncology World Congress<\/p>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
Frankfurt, Germany<\/p>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
It is our pleasure to invite you to participate in\u00a0The 4th<\/sup> Immuno-Oncology World Congress (Immuno-Oncology2023)<\/strong>\u00a0which will take place\u00a04-5 December 2023<\/strong>\u00a0in\u00a0Frankfurt, Germany.<\/strong><\/span><\/p> Immuno-Oncology2023<\/strong>\u00a0will focus on the latest developments and findings in immuno-oncology therapy as well as targeted therapy. The Congress will examine treatments available on the market as well as treatments still in the development stage. The Congress will welcome Oncologists, Dermatologists, Immunologists, Surgical Oncologists, clinical scientists, industry leaders and other experts.<\/span><\/p> The congress will focus on the following key areas:<\/span><\/p> \u2022 Selecting patients for treatment with immunotherapy<\/span> You are invited and encouraged to contribute to the program by submitting an abstract for oral and poster presentation and we look forward to your active involvement.<\/span><\/p> We look forward to seeing you at\u00a0Immuno-Oncology2023<\/strong>\u00a0in the beautiful city of Frankfurt.<\/span><\/p> Sincerely,<\/span><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t Sheba Medical Center, Israel<\/p>\n Congress Co-Chair<\/p>\n\t\t\t\t\t<\/div>\n\t\t\t\t\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t University Hospital Essen, Germany<\/p>\n Congress Co-Chair<\/p>\n\t\t\t\t\t<\/div>\n\t\t\t\t\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\u2022 Biologic markers in Immuno-Oncology<\/span>
\u2022 The current drugs available in immunotherapy (and combinations)<\/span>
\u2022 Cell therapy<\/span>
\u2022 Future directions in Immuno-Oncology<\/span>
\u2022 Evaluating response in immunotherapy<\/span>
\u2022 Toxicity management of immunotherapy drugs<\/span><\/p>\n\t\t\t\t<\/div>\n\t\t\t\n\t\t\t
\n\t\t\t\t\t\t\tProf. Jacob Schachter\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t<\/div>\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t<\/div>\n\t\t\t\n\t\t\t
\n\t\t\t\t\t\t\tProf. Dr. Dirk Schadendorf\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t<\/div>\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t
SIGN UP FOR OUR NEWSLETTER<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t